PH26972A - Pharmaceutical compositions containing ranitidine - Google Patents

Pharmaceutical compositions containing ranitidine Download PDF

Info

Publication number
PH26972A
PH26972A PH40086A PH40086A PH26972A PH 26972 A PH26972 A PH 26972A PH 40086 A PH40086 A PH 40086A PH 40086 A PH40086 A PH 40086A PH 26972 A PH26972 A PH 26972A
Authority
PH
Philippines
Prior art keywords
pharmaceutical composition
ranitidine
filling
composition according
mixture
Prior art date
Application number
PH40086A
Other languages
English (en)
Inventor
Shan Kumar Chopra
Tribhovan Tarun Mafadia
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of PH26972A publication Critical patent/PH26972A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH40086A 1989-02-23 1990-02-22 Pharmaceutical compositions containing ranitidine PH26972A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PH26972A true PH26972A (en) 1992-12-28

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
PH40086A PH26972A (en) 1989-02-23 1990-02-22 Pharmaceutical compositions containing ranitidine

Country Status (26)

Country Link
US (1) US5028432A (cg-RX-API-DMAC7.html)
JP (1) JP2856817B2 (cg-RX-API-DMAC7.html)
KR (1) KR940006271B1 (cg-RX-API-DMAC7.html)
AT (1) AT401727B (cg-RX-API-DMAC7.html)
AU (1) AU629303B2 (cg-RX-API-DMAC7.html)
BE (1) BE1003123A3 (cg-RX-API-DMAC7.html)
CA (1) CA2010692C (cg-RX-API-DMAC7.html)
CH (1) CH680567A5 (cg-RX-API-DMAC7.html)
CY (1) CY1734A (cg-RX-API-DMAC7.html)
DE (1) DE4005650C2 (cg-RX-API-DMAC7.html)
DK (1) DK170209B1 (cg-RX-API-DMAC7.html)
FR (1) FR2643263B1 (cg-RX-API-DMAC7.html)
GB (2) GB8904182D0 (cg-RX-API-DMAC7.html)
HK (1) HK89493A (cg-RX-API-DMAC7.html)
HU (1) HU211930A9 (cg-RX-API-DMAC7.html)
IE (1) IE63179B1 (cg-RX-API-DMAC7.html)
IL (1) IL93490A (cg-RX-API-DMAC7.html)
IT (1) IT1240768B (cg-RX-API-DMAC7.html)
LU (1) LU87681A1 (cg-RX-API-DMAC7.html)
NL (1) NL193267C (cg-RX-API-DMAC7.html)
NZ (1) NZ232642A (cg-RX-API-DMAC7.html)
PH (1) PH26972A (cg-RX-API-DMAC7.html)
SA (1) SA90100287B1 (cg-RX-API-DMAC7.html)
SE (1) SE512412C2 (cg-RX-API-DMAC7.html)
ZA (1) ZA901348B (cg-RX-API-DMAC7.html)
ZW (1) ZW1790A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8546591A (en) * 1990-09-13 1992-04-15 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
ATE157867T1 (de) * 1992-10-16 1997-09-15 Glaxo Group Ltd Geschmacksmaskierende zusammensetzungen von ranitidin
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
DE60222803T2 (de) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. Orale kapselformulierung mit verbesserter physikalischer stabilität
WO2004069180A2 (en) * 2003-01-31 2004-08-19 Smithkline Beecham Corporation Solid dispersion compositions
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
EP2585025B2 (en) 2010-06-23 2022-10-26 Colgate-Palmolive Company Therapeutic oral composition
BR112013015571A8 (pt) 2010-12-20 2017-03-28 Colgate Palmolive Co Composição para cuidado oral encapsulada de gelatina contendo ativos de oclusão dentária, modificador de viscosidade hidrofóbico e carreador oleoso
PH12013501078A1 (en) 2010-12-20 2018-03-21 Colgate Palmolive Co Gelatin encapsulated oral care composition containing hydrophilic active hydrophobic structuring agent and oil carrier
MY163496A (en) 2010-12-20 2017-09-15 Colgate Palmolive Co Non-aqueous oral care composition containing dental occlusion actives
RU2761346C2 (ru) * 2016-11-01 2021-12-07 Джонсон энд Джонсон Консьюмер Инк. Жидкая пероральная фармацевтическая лекарственная форма, содержащая антагонист h2-рецептора гистамина и антацид
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물
JP7556847B2 (ja) * 2018-09-07 2024-09-26 アール．ピー．シェーラー テクノロジーズ，エルエルシー 硬化および低ｈｌｂ界面活性剤の添加による固体または半固体脂質ベースの剤形の安定化

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
GB2084580B (en) * 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
EP0077529B1 (de) * 1981-10-16 1985-07-17 Sanol Schwarz GmbH Arzneimittelformulierung
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
AU556989B2 (en) * 1983-08-01 1986-11-27 R.P. Scherer Corporation Sustained release method and product
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
IE60726B1 (en) * 1988-09-20 1994-08-10 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
SA90100287B1 (ar) 1999-08-15
NL9000428A (nl) 1990-09-17
IL93490A0 (en) 1990-11-29
LU87681A1 (fr) 1991-10-08
SE9000625D0 (sv) 1990-02-22
JPH03200728A (ja) 1991-09-02
SE9000625L (sv) 1990-08-24
AT401727B (de) 1996-11-25
ATA42190A (de) 1996-04-15
IL93490A (en) 1994-07-31
JP2856817B2 (ja) 1999-02-10
KR940006271B1 (ko) 1994-07-14
FR2643263B1 (fr) 1994-09-16
GB2229094A (en) 1990-09-19
GB8904182D0 (en) 1989-04-05
NL193267C (nl) 1999-05-06
DK48090A (da) 1990-08-24
CA2010692A1 (en) 1990-08-23
CA2010692C (en) 1995-12-12
DE4005650A1 (de) 1990-09-06
CH680567A5 (cg-RX-API-DMAC7.html) 1992-09-30
ZW1790A1 (en) 1991-10-16
GB2229094B (en) 1993-01-06
SE512412C2 (sv) 2000-03-13
DK170209B1 (da) 1995-06-19
BE1003123A3 (fr) 1991-12-03
AU629303B2 (en) 1992-10-01
IT9047659A0 (it) 1990-02-22
IE63179B1 (en) 1995-03-22
CY1734A (en) 1994-05-06
IT1240768B (it) 1993-12-17
NZ232642A (en) 1992-07-28
FR2643263A1 (fr) 1990-08-24
HK89493A (en) 1993-09-03
DE4005650C2 (de) 1999-03-25
IT9047659A1 (it) 1991-08-22
AU5007390A (en) 1990-08-30
US5028432A (en) 1991-07-02
HU211930A9 (en) 1996-01-29
NL193267B (nl) 1999-01-04
IE900651L (en) 1990-08-23
ZA901348B (en) 1991-03-27
DK48090D0 (da) 1990-02-22
GB9004016D0 (en) 1990-04-18
KR900012612A (ko) 1990-09-01

Similar Documents

Publication Publication Date Title
US5028432A (en) Pharmaceutical capsules containing panetidine
ES2379626T3 (es) Composiciones y procedimientos para la administración mejorada de agentes terapéuticos hidrófobos
KR910000655B1 (ko) 신규 형태의 연질캡슐 제조방법
WO1986004503A1 (en) Pharmaceutical composition containing ubidecarenone
HUT75670A (en) Soft-shelled gelatin encapsulated particles and process for its production
AU1168099A (en) Formulations comprising dissolved paroxetine
US20020032220A1 (en) Formulations comprising dissolved paroxetine
EP0326103B1 (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
EP0431659B1 (en) Pharmaceutical compositions of tebufelone
CA2388474A1 (en) Vasopressin antagonist formulation and process
JPS61200909A (ja) 経口投与持続性カプセル剤
JPS59106418A (ja) ニフエジピン製剤
JPH0420891B2 (cg-RX-API-DMAC7.html)
JP2000355552A (ja) オキサトミド製剤
CZ20001876A3 (cs) Prostředky obsahující rozpuštěný paroxetin
CA2310407A1 (en) Formulations comprising dissolved paroxetine
MXPA00005030A (en) Formulations comprising dissolved paroxetine